Human essential hypertension now challenges global public health, affecting hundreds of millions worldwide. This complex, multifactorial, and polygenic disease plays a crucial role in causing cardiovascular disease. Despite many effective treatments, researchers have yet to unravel its genetic basis even after centuries of study. Understanding the genetics behind essential hypertension (EH) may lead to more effective therapies and prevention.
Researchers are increasingly focused on uncovering genetic hypertension causes to understand why this condition affects millions globally.
Major Genetic Hypertension Causes in Humans
Classification of Hypertension
Experts classify hypertension broadly into two groups: those with a known cause (secondary hypertension) and those without a known cause, called essential hypertension (EH). Researchers have identified several mutations causing Mendelian forms of hypertension—where a single gene mutation causes disease—but identifying genes involved in EH has proven more difficult.
The Genetic Search for EH
Luft (2004) questioned whether we know the genes causing EH. The answer might lie in the methodologies and species scientists use for discovery.
Researchers mainly use genome-wide scans and candidate gene approaches to find hypertension-related genes.
How Genome-wide Scans Reveal Genetic Hypertension Causes
Genome-wide scans examine the entire genome for quantitative trait loci (QTLs), revealing chromosomal regions that may control traits like blood pressure (BP). However, environmental factors weaken and obscure genotype-phenotype associations in complex traits like EH. Consequently, many studies face false positives and negatives, complicating gene identification.
Recently, two major genome-wide scans—the Family Blood Pressure Programme (FBPP) and the British Genetics of Hypertension (BRIGHT) study—have sought hypertension-linked genomic regions. FBPP found a significant region on chromosome 1q associated with diastolic BP, while BRIGHT found a significant locus on chromosome 6q and suggestive linkages on chromosomes 2q, 5q, and 9q. Variations in study design, markers, and inheritance patterns, however, make interpreting these results difficult.
Genome-wide studies aim to identify genetic hypertension causes by mapping the chromosomal regions linked to elevated blood pressure.
Candidate Gene Approach: Limited Success
The candidate gene approach links EH with gene variations known for physiological relevance but yields modest results. Researchers face challenges such as inadequate phenotyping, hidden population stratification, and low statistical power.
Ioannidis et al. (2001) proposed criteria for high-quality association studies: significant P-values that survive multiple testing corrections, large sample sizes, demonstrated biological plausibility and functional significance, and replication across populations. Meeting all criteria remains challenging in human studies.
Animal Models: An Emerging Road
Given the complexities of human studies, researchers find promise in animal models. Inbred rat strains with inherited hypertension, like spontaneously hypertensive rats (SHRs) and Dahl salt-sensitive rats, help identify genes related to EH.
Animal research plays a crucial role in isolating genetic hypertension causes, allowing scientists to test and confirm gene-specific effects.
Congenic and Consomic Rat Strains
Researchers create congenic strains by backcrossing a chromosomal region from one strain onto another and consomic strains by transferring entire chromosomes. These strategies reduce genetic variability and help pinpoint QTLs for hypertension.
Scientists have mapped at least one QTL for blood pressure on almost every rat chromosome, highlighting hypertension’s polygenic nature. Still, narrowing QTLs and identifying responsible genes remain challenging. So far, congenic mapping led to only one successful gene cloning linked to hypertension (Cicila et al., 2001).
Other Genetic Approaches
Researchers use knockout, knockin, transgenic models, and RNA interference to determine individual gene contributions to hypertension. These techniques are not yet fully exploited in hypertension research but promise significant advances.
The Use of Microarray Technology in Hypertension Research
Advances in molecular biology now allow researchers to analyze large-scale gene expression using microarray technology, which measures expression levels of nearly all genes in a sample.
Researchers have integrated microarray technology with congenic mapping to identify glutathione S-transferase µ-type 1 as a potential hypertension contributor (McBride et al., 2003). However, human applications remain challenging due to the need for tissue biopsies, though researchers expect to overcome these obstacles soon.
The Future of Hypertension Genetics
Human and animal studies underscore hypertension’s complexity as a polygenic disorder. Genome scans suggest no major genes exert large effects on blood pressure; instead, multiple genes likely contribute modestly, cumulatively increasing hypertension risk.
Future research must confirm linkage peaks and identify disease-predisposing variants. Studying gene-environment interactions and leveraging SNP haplotyping may unlock breakthroughs in hypertension genetics.
A Call for Collaborative Research
Although researchers increasingly understand EH mechanisms and treatments, genetic knowledge gaps persist. Scientists from diverse disciplines must collaborate to bridge these gaps, accelerating gene discovery and improving patient outcomes worldwide.
Read More Topics:
- First oral GLP-1 weight-loss pill approved a new era for accessible treatment
- Chewing gum releases thousands of microplastic particles directly into your mouth with every piece you chew
- Scientists Created a New Chikungunya Vaccine That Stops the Virus From Fully Spreading in the Body
- Single-Cell Study of Over a Million Immune Cells Reveals Why Women Are More Prone to Autoimmune Disease
- Low Sexual Frequency Linked to Worse Cardiovascular Outcomes, Two US Studies Find
